


| Key | % Net Assets |
|---|---|
| 6.0% | |
| 5.7% | |
| 5.2% | |
| 5.0% | |
| 78.1% |
| Name | % Net Assets |
|---|---|
| Royal Dutch Shell | 6.0% |
| GlaxoSmithKline | 5.7% |
| ANGLO AMERICAN | 5.2% |
| BG GROUP | 5.0% |
| GLAXOSMITHKLINE | 5.0% |
| RIO TINTO | 4.6% |
| ASTRAZENECA PLC | 4.3% |
| UNILEVER | 4.3% |
| HSBC HLDGS | 4.1% |
| BP | 3.6% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 264.50p |
| Currency | GBP |
| Change | 0.30p |
| % | 0.11% |
| YTD change | 28.80p |
| YTD % | 12.22% |
| Fund Inception | 06/05/1997 |
|---|---|
| Fund Manager | Jeremy Smith |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £1000000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.13 |
You are here: research